ダークモードに切り替えて、より持続可能な世界を一緒に目指しましょう。詳細はこちら
"},"globalSiteLink":{"text":"Global","href":"https://www.gsk.com","target":"_blank","openInNewWindowText":"新しいウィンドウで開く"},"locationSelector":{"text":"Location selector","href":"/ja-jp/locations/","openInNewWindowText":null},"healthCareLink":{"text":"医療関係者向け情報","href":"https://gskpro.com/","target":"_blank","openInNewWindowText":"新しいウィンドウで開く"},"contactUs":{"text":"お問い合わせ","href":"/ja-jp/contact-us/","openInNewWindowText":null},"search":"検索する","backToMain":"Back to main","menu":"Menu","closeMenu":"閉じる","animationsToggleModel":{"enable":true,"activeText":"ビデオを一時停止する","inactiveText":"ビデオを再生する"}},"nodes":[{"tooltip":null,"hasBorderRight":false,"title":"GSKについて","url":"/ja-jp/company/","nodes":[{"title":"存在意義・戦略・カルチャー","url":"/ja-jp/company/purpose-strategy-and-culture/","nodes":[],"isActive":false},{"title":"日本法人 会社概要","url":"/ja-jp/company/at-a-glance/","nodes":[{"title":"今市工場～適切な品質の医薬品を確実にお届けする","url":"/ja-jp/company/at-a-glance/about-imaichi-factory/","nodes":[],"isActive":false}],"isActive":false},{"title":"日本法人社長メッセージ","url":"/ja-jp/company/president-message/","nodes":[],"isActive":false},{"title":"行動指針","url":"/ja-jp/company/policies-codes-and-standards/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"存在意義・戦略・カルチャー","image":{"src":"/media/psrlzurd/gsk_tech_human_image_6k_30056.png?width=329&height=185&format=webp&quality=100&v=1dc0141891810b0","alt":"存在意義・戦略・カルチャー","darkModeSrc":"/media/psrlzurd/gsk_tech_human_image_6k_30056.png?width=329&height=185&format=webp&quality=90&v=1dc0141891810b0"},"link":{"text":"FEATURED SECTION","href":"/ja-jp/company/purpose-strategy-and-culture/","openInNewWindowText":null}},{"text":"採用情報","image":{"src":"/media/nnqgbuwz/_s3a0516_600x337.jpg?width=329&height=185&format=webp&quality=100&v=1dc0141e3b9aa10","alt":"採用情報","darkModeSrc":"/media/nnqgbuwz/_s3a0516_600x337.jpg?width=329&height=185&format=webp&quality=90&v=1dc0141e3b9aa10"},"link":{"text":"SPOTLIGHT ON","href":"/ja-jp/careers/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"イノベーション","url":"/ja-jp/innovation/","nodes":[{"title":"疾患領域","url":"/ja-jp/innovation/therapeutic-areas/","nodes":[{"title":"呼吸器・免疫・炎症","url":"/ja-jp/innovation/therapeutic-areas/respiratory-immunology-and-inflammation/","nodes":[],"isActive":false},{"title":"オンコロジー","url":"/ja-jp/innovation/therapeutic-areas/oncology/","nodes":[],"isActive":false},{"title":"HIV","url":"/ja-jp/innovation/therapeutic-areas/hiv/","nodes":[],"isActive":false},{"title":"感染症","url":"/ja-jp/innovation/therapeutic-areas/infectious-diseases/","nodes":[],"isActive":false}],"isActive":false},{"title":"開発パイプライン","url":"/ja-jp/innovation/pipeline/","nodes":[],"isActive":false},{"title":"臨床試験","url":"/ja-jp/innovation/trials-in-people/","nodes":[{"title":"臨床試験とは","url":"/ja-jp/innovation/trials-in-people/about-trials-in-people/","nodes":[],"isActive":false},{"title":"治験結果","url":"/ja-jp/innovation/trials-in-people/simple-trial-data/","nodes":[],"isActive":false},{"title":"治験情報 免責事項","url":"/ja-jp/innovation/trials-in-people/clinical-trial-information-notice/","nodes":[],"isActive":false},{"title":"データ二次利用による臨床研究の公開","url":"/ja-jp/innovation/trials-in-people/clinical-trials-optout/","nodes":[],"isActive":false}],"isActive":false}],"isActive":false,"promos":[{"text":"開発パイプライン","image":{"src":"/media/xebp324o/ware_3_2022_prodqc_14_hess.jpg?width=329&height=185&format=webp&quality=100&v=1dc01418c117a90","alt":"開発パイプライン","darkModeSrc":"/media/xebp324o/ware_3_2022_prodqc_14_hess.jpg?width=329&height=185&format=webp&quality=90&v=1dc01418c117a90"},"link":{"text":"FEATURED SECTION","href":"/ja-jp/innovation/pipeline/","openInNewWindowText":null}},{"text":"Global Innovation","image":{"src":"/media/gffdghl1/web03-header-stvg_2_2022_port_5_hess_mnav.jpg?width=329&height=185&format=webp&quality=100&v=1dc01418beded00","alt":"イノベーション","darkModeSrc":"/media/gffdghl1/web03-header-stvg_2_2022_port_5_hess_mnav.jpg?width=329&height=185&format=webp&quality=90&v=1dc01418beded00"},"link":{"text":"SPOTLIGHT ON","href":"https://www.gsk.com/en-gb/innovation/","target":"_blank","openInNewWindowText":"新しいウィンドウで開く"}}]},{"tooltip":null,"hasBorderRight":false,"title":"製品情報","url":"/ja-jp/products/","nodes":[{"title":"医療用医薬品（患者さま向けくすりの情報）","url":"/ja-jp/products/our-prescription-medicines/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"イノベーション","image":{"src":"/media/qtbfhkic/otsuki-san.jpg?width=329&height=185&format=webp&quality=100&v=1dc01418c60d310","alt":"イノベーション","darkModeSrc":"/media/qtbfhkic/otsuki-san.jpg?width=329&height=185&format=webp&quality=90&v=1dc01418c60d310"},"link":{"text":"SPOTLIGHT ON","href":"/ja-jp/innovation/","openInNewWindowText":null}},{"text":"医療関係の皆さま向けサイト","image":{"src":"/media/s0npmulr/navthumb_stvg_03_2022_port_32_eagle_orange-1_mnav.jpg?width=329&height=185&format=webp&quality=100&v=1dc01418e842840","alt":"医療関係の皆さま向けサイト","darkModeSrc":"/media/s0npmulr/navthumb_stvg_03_2022_port_32_eagle_orange-1_mnav.jpg?width=329&height=185&format=webp&quality=90&v=1dc01418e842840"},"link":{"text":"FEATURED WEBSITE","href":"https://gskpro.com/","target":"_blank","openInNewWindowText":"新しいウィンドウで開く"}}]},{"tooltip":null,"hasBorderRight":true,"title":"企業責任","url":"/ja-jp/responsibility/","nodes":[{"title":"アクセス","url":"/ja-jp/responsibility/access/","nodes":[],"isActive":false},{"title":"グローバルへルスとヘルスセキュリティ","url":"/ja-jp/responsibility/global-health-and-health-security/","nodes":[],"isActive":false},{"title":"環境","url":"/ja-jp/responsibility/environment/","nodes":[],"isActive":false},{"title":"インクルージョン ","url":"/ja-jp/responsibility/inclusion/","nodes":[{"title":"日本におけるLGBTQ＋に対する取り組み","url":"/ja-jp/responsibility/inclusion/lgbtqplus/","nodes":[],"isActive":false}],"isActive":false},{"title":"倫理基準","url":"/ja-jp/responsibility/ethical-standards/","nodes":[{"title":"医療機関及び医療関係者との関係の透明性","url":"/ja-jp/responsibility/ethical-standards/transparency-hcps/","nodes":[],"isActive":false},{"title":"患者団体との関係の透明性","url":"/ja-jp/responsibility/ethical-standards/transparency-patient-groups/","nodes":[],"isActive":false},{"title":"贈収賄防止への取り組み","url":"/ja-jp/responsibility/ethical-standards/efforts-to-bribery-prevention/","nodes":[],"isActive":false}],"isActive":false},{"title":"製品ガバナンス","url":"/ja-jp/responsibility/product-governance/","nodes":[],"isActive":false},{"title":"医学・薬学に関連する団体や患者団体への支援","url":"/ja-jp/responsibility/grants-donations/","nodes":[],"isActive":false},{"title":"GSK医学教育事業助成","url":"/ja-jp/responsibility/ime-grant/","nodes":[],"isActive":false},{"title":"患者団体との協働","url":"/ja-jp/responsibility/our-support/","nodes":[],"isActive":false},{"title":"新型インフルエンザへの対応","url":"/ja-jp/responsibility/influenza/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"インクルージョン","image":{"src":"/media/xj0ln5vy/s3a1341_600x350.jpg?width=329&height=185&format=webp&quality=100&v=1dc014192cf3f70","alt":"ダイバーシティ・エクイティ＆インクルージョン","darkModeSrc":"/media/xj0ln5vy/s3a1341_600x350.jpg?width=329&height=185&format=webp&quality=90&v=1dc014192cf3f70"},"link":{"text":"FEATURED SECTION","href":"/ja-jp/responsibility/inclusion/","openInNewWindowText":null}},{"text":"行動指針","image":{"src":"/media/f5rg2rd1/gsk_texture_fluid_03_a_cmyk_web-size_nav.jpg?width=329&height=185&format=webp&quality=100&v=1dc014185d800e0","alt":"行動指針","darkModeSrc":"/media/f5rg2rd1/gsk_texture_fluid_03_a_cmyk_web-size_nav.jpg?width=329&height=185&format=webp&quality=90&v=1dc014185d800e0"},"link":{"text":"SPOTLIGHT ON","href":"/ja-jp/company/policies-codes-and-standards/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"ニュース","url":"/ja-jp/news/","nodes":[{"title":"報道関係の皆さま向けのお知らせ（プレスリリース）","url":"/ja-jp/news/press-releases/","nodes":[],"isActive":false},{"title":"報道関係の皆さま向けのお問い合わせ","url":"/ja-jp/news/media-contacts/","nodes":[],"isActive":false},{"title":"医療関係の皆さまへのお知らせ","url":"/ja-jp/news/healthcare-professionals/","nodes":[],"isActive":false},{"title":"一般・患者の皆さまのへお知らせ","url":"/ja-jp/news/consumers/","nodes":[],"isActive":false},{"title":"その他のお知らせ","url":"/ja-jp/news/responsibility-news/","nodes":[],"isActive":false},{"title":"注目の取り組み","url":"/ja-jp/news/in-focus/","nodes":[{"title":"疾患情報サイト（患者さま向け）","url":"/ja-jp/news/in-focus/disease-information/","nodes":[],"isActive":false}],"isActive":false},{"title":"私たちのソーシャルメディア","url":"/ja-jp/news/our-social-media/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"疾患情報サイト（患者さま向け）","image":{"src":"/media/xmdfpoex/disease-information_navi.jpg?width=329&height=185&format=webp&quality=100&v=1dc0141d77b8250","alt":"疾患情報サイト（患者さま向け）","darkModeSrc":"/media/xmdfpoex/disease-information_navi.jpg?width=329&height=185&format=webp&quality=90&v=1dc0141d77b8250"},"link":{"text":"FEATURED SECTION","href":"/ja-jp/news/in-focus/disease-information/","openInNewWindowText":null}}]},{"tooltip":null,"hasBorderRight":false,"title":"採用情報","url":"/ja-jp/careers/","nodes":[{"title":"Life at GSK – GSKで働く","url":"/ja-jp/careers/life-at-gsk/","nodes":[{"title":"社員の能力開発","url":"/ja-jp/careers/life-at-gsk/developing-our-people/","nodes":[],"isActive":false},{"title":"社員の健康、安全および福利","url":"/ja-jp/careers/life-at-gsk/emploee-health-safety-and-well-being/","nodes":[],"isActive":false},{"title":"パフォーマンスに対する報酬","url":"/ja-jp/careers/life-at-gsk/rewarding-performance/","nodes":[],"isActive":false},{"title":"人事制度のご案内","url":"/ja-jp/careers/life-at-gsk/personnel-system/","nodes":[],"isActive":false}],"isActive":false},{"title":"中途採用","url":"/ja-jp/careers/experienced-professionals/","nodes":[],"isActive":false},{"title":"募集職種・エントリー","url":"/ja-jp/careers/recruitment/","nodes":[],"isActive":false},{"title":"人財本部長からのメッセージ","url":"/ja-jp/careers/message/","nodes":[],"isActive":false},{"title":"社員の声","url":"/ja-jp/careers/our-people-interview/","nodes":[],"isActive":false}],"isActive":true,"promos":[{"text":"社員の声","image":{"src":"/media/cr1piyay/interview_navi.jpg?rxy=0.48166666666666669,0.35207100591715978&width=329&height=185&format=webp&quality=100&v=1dc0141e83a9e50","alt":"社員の声","darkModeSrc":"/media/cr1piyay/interview_navi.jpg?rxy=0.48166666666666669,0.35207100591715978&width=329&height=185&format=webp&quality=90&v=1dc0141e83a9e50"},"link":{"text":"FEATURED SECTION","href":"/ja-jp/careers/our-people-interview/","openInNewWindowText":null}}]}],"skipToContent":null,"skipToSearch":null,"typeaheadSearch":{"apiEndpoint":"api/search/typeahead?siteContainerId=1703","searchFieldPlaceholderText":"検索する","searchPage":"/ja-jp/search/","ariaLabel":"Submit form"},"ariaLabel":"Global navigation"},"footer":{"logo":null,"copyrightText":"当サイトに掲載されている情報は日本国内に居住されている方のためのもので、日本の事業に関する情報を求める方を対象とした日本のウェブサイトです。
GSKグローバルサイト（英語）はLocation selectorからアクセスいただけます。
© 2001-2026 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies.
\nGSK plc. Registered in England and Wales No. 3888792.
\nグラクソ・スミスクライン株式会社
東京都港区赤坂1-8-1 赤坂インターシティAIR
これからアクセスしようとしているウェブサイトの内容は、グラクソ・スミスクライン株式会社によって管理されているものではありません。その正確性、安全性、信頼性はグラクソ・スミスクライン株式会社が保証しているものではないことをご了承ください。
","continueText":"続ける","cancelText":"戻る","exclusionUrls":["https://jp.gsk.com","https://jp.gsk.com/","https://gskpro.com/","https://gskpro.com/ja-jp/","https://gskpro.com/ja-jp/yakuzaishi/","https://kusurigsk.jp/","http://kusurigsk.jp/","https://glaxosmithkline.co.jp/","https://glaxosmithkline.co.jp/gsk-chj/","https://glaxosmithkline.co.jp/gsk-chj/products/","https://glaxosmithkline.co.jp/gsk-chj/contact-us/dental-care/","https://glaxosmithkline.co.jp/gsk-chj/contact-us/nonprescription/","https://glaxosmithkline.co.jp/legal/inquire3_1.html","https://glaxosmithkline.co.jp/legal/inquire3_1.html?about=medicine1&ref=GSKCorporate","https://glaxosmithkline.co.jp/legal/inquire3_1.html?about=medicine2&ref=GSKCorporate","https://glaxosmithkline.co.jp/legal/inquire3_1.html?about=sideeffect&ref=vaccine","https://glaxosmithkline.co.jp/legal/inquire3_1.html?about=research&ref=GSKCorporate","https://glaxosmithkline.co.jp/legal/inquire3_1.html?about=recruit&ref=GSKCorporate","https://glaxosmithkline.co.jp/legal/inquire3_1.html?about=media&ref=GSKCorporate","https://glaxosmithkline.co.jp/legal/inquire3_1.html?about=privacy&ref=GSKCorporate","https://glaxosmithkline.co.jp/legal/inquire3_1.html?about=compliance&ref=GSKCorporate","https://glaxosmithkline.co.jp/legal/inquire3_1.html?about=other&ref=GSKCorporate","https://glaxosmithkline.co.jp/viiv/index.html","https://glaxosmithkline.co.jp/crsf/healthcare/","https://jobs.gsk.com/ja-jp/jobs","https://youtu.be/z5bVnkcBEQo?rel=0","https://www.facebook.com/glaxosmithkline.japan/","https://privacy.gsk.com/ja-jp/privacy-notice/general/","https://btx-a.jp/kao/","https://btx-a.jp/kubi/","https://btx-a.jp/shoni/","http://keishuku.jp/","http://waki-ase.jp/","https://pah.jp/","https://hainyo-onayami.jp/","http://jp.gsk.com/","http://lovesbaby.jp/","https://taijouhoushin-yobou.jp/","http://allwomen.jp/","https://www.broughtbyvaccines.com/ja-jp/","https://jpv5.staging.gsk.com/#market-selector","https://jp.gsk.com/ja-jp/#market-selector","https://kusurigsk.jp/aaa/","https://kusurigsk.jp/aa/","https://kusurigsk.jp/al/","https://kusurigsk.jp/sul/","https://kusurigsk.jp/sere/","https://kusurigsk.jp/sered/","https://kusurigsk.jp/ft/","https://kusurigsk.jp/ftd/","https://kusurigsk.jp/fta/","https://gskpro.com/ja-jp/products-info/relenza/","https://keiren.jp/","https://shakei.jp/","https://shoni.jp/","https://acsprtnavi.c-nuage.jp/~gsk_rg/as/application/toppage","https://acsprtnavi.c-nuage.jp/~gsk/as/application/toppage","https://taijouhoushin-yobou.jp/?utm_source=pr&utm_medium=press_release&utm_campaign=gsk","https://www.broughtbyvaccines.com/ja-jp/?utm_source=pr&utm_medium=press_release&utm_campaign=gsk","https://broughtbyvaccines.com/ja-jp/","https://glaxosmithkline.co.jp/corp/compliance/view/","https://glaxosmithkline.co.jp/corp/compliance/view/index2019.html","https://glaxosmithkline.co.jp/corp/compliance/view/agree_advance.php?t=T-SEARCH","https://glaxosmithkline.co.jp/corp/compliance/patient/agree.html","https://allwomen.jp/","https://www.gskhealthpartner.com/ja-jp/oral-health/","https://glaxosmithkline.co.jp/corp/compliance/view/index2020.html","https://privacy.gsk.com/ja-jp/privacy-notice/","http://www.gsk.com","https://www.gsk.com","https://www.gsk.com/","https://www.gsk.com/en-gb/behind-the-science/","https://supplier.gsk.com/irj/portal/public","https://gsk.i-sight.com/landing-page/","https://www.gsk.com/en-gb/innovation/research-and-development-approach/","https://www.gsk.com/en-gb/innovation/partnerships/","https://www.gsk.com/media/7473/esg-performance-report-2021.pdf","https://www.gsk.com/media/8519/the-code-printable-version.pdf","https://www.gsk.com/media/8518/policies-and-standards.pdf","https://www.gsk.com/en-gb/company/gsk-at-a-glance/","https://www.gsk.com/media/8519/the-code-printable-version.pdf","https://www.gsk.com/media/8518/policies-and-standards.pdf","https://www.gsk.com/media/9281/gsk-position-on-working-with-third-parties-december-2019.pdf","https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/binding-corporate-rules/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/","https://www.gsk.com/en-gb/innovation/pipeline/","https://www.gsk.com/en-gb/research-and-development/trials-in-people/gsk-study-register-and-patient-level-data/","https://www.gsk.com/en-gb/products/our-product-areas/","https://www.gsk.com/en-gb/responsibility/pricing-and-access/","https://www.gsk.com/en-gb/responsibility/global-health-and-health-security/","https://www.gsk.com/en-gb/responsibility/environmental-sustainability/","https://www.gsk.com/en-gb/responsibility/product-governance/","https://us.gsk.com/en-us/about-us/us-community-partnerships/stem-education/philadelphia-stem-equity-collective/","https://www.gsk.com/en-gb/responsibility/charitable-partnerships/","https://www.gsk.com/en-gb/company/governance/compliance/","https://www.gsk.com/en-gb/responsibility/ethical-standards/","https://www.gsk.com/en-gb/responsibility/ethical-standards/working-with-third-parties/","https://www.gsk.com/en-gb/responsibility/ethical-standards/public-policy-and-patient-advocacy/","https://www.gsk.com/en-gb/responsibility/ethical-standards/human-rights/","https://www.gsk.com/en-gb/responsibility/ethical-standards/use-of-animals/","https://www.gsk.com/en-gb/responsibility/ethical-standards/engaging-with-healthcare-professionals/","https://www.gsk.com/en-gb/responsibility/operating-responsibly/ethics-and-values/","https://www.gsk.com/en-gb/careers/","https://www.gsk.com/en-gb/innovation/","https://www.gsk.com/media/9632/q3-2022-results-announcement.pdf","https://www.gsk.com/en-gb/media/press-releases/us-food-and-drug-administration-accepts-new-drug-application-for-daprodustat/","https://www.gsk.com/en-gb/media/press-releases/gsk-receives-first-regulatory-approval-for-duvroq-daprodustat-in-japan-for-patients-with-anaemia-due-to-chronic-kidney-disease/","https://www.gsk.com/media/9384/understanding-our-value-chain-carbon-footprint.pdf","https://www.gsk.com/media/9374/understanding-our-value-chain-water-footprint.pdf","https://www.gsk.com/en-gb/responsibility/environmental-sustainability/biodiversity/","https://www.gsk.com/media/9386/q2-2022-results-announcement.pdf","https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Sotrovimab/pdf/SOTROVIMAB-EUA.PDF#nameddest=HCPFS","https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Sotrovimab/pdf/SOTROVIMAB-PATIENT-FACT-SHEET.PDF","https://www.ema.europa.eu/en/news/ema-issues-advice-use-sotrovimab-vir-7831-treating-covid-19","https://www.gsk.com/en-gb/media/press-releases/ema-issues-positive-scientific-opinion-on-gsk-and-vir-biotechnology-s-sotrovimab-for-the-early-treatment-of-covid-19/","https://www.gsk.com/en-gb/media/press-releases/gsk-and-vir-biotechnology-announce-sotrovimab-vir-7831-receives-emergency-use-authorization-from-the-us-fda/","https://www.gsk.com/en-gb/about-us/","https://gskpro.com/content/dam/global/hcpportal/ja_JP/products-info/nucala/nucala.pdf","https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Nucala/pdf/NUCALA-PI-PIL-IFU-COMBINED.PDF","https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Tre%20legy/pdf/TRELEGY-PI-MG-IFU.PDF","https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Nucala/pdf/NUCALA-PI-PIL.PDF","https://www.gsk-clinicalstudyregister.com/study/116855?search=study&search_terms=FF%2FUMEC%2FVI%2B&ps","https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Trelegy/pdf/TRELEGY-PI-MG-IFU.PDF","https://www.gsksource.com/pharma/content/gsk/source/us/en/brands/nucala/pi/saep.html","https://livlife.com/jp-jp/","https://gskpro.com/ja-jp/products-info/lamictal-epi/adult-dosage/","https://gskpro.com/ja-jp/products-info/lamictal-bp/dosage/","https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Breo_Ellipta/pdf/BREO-ELLIPTA-PI-MG.PDF","http://jp.gsk.com","http://jp.gsk.com/","http://www.gsk.com/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/infectious-diseases/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/hiv/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/oncology/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/immunology/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/opportunity-driven/","https://viivhealthcare.com/","https://www.youtube.com/embed/zqwxYjuEtaY","https://www.youtube.com/watch?v=ibGWPULYxdM","https://www.facebook.com/GSK","https://twitter.com/GSK","https://www.youtube.com/GSK","http://www.linkedin.com/company/glaxosmithkline","https://www.instagram.com/gsk/","https://www.gsk.com/en-gb/innovation/technologies/","https://www.gsk.com/en-gb/innovation/rd-locations/","https://www.gsk.com/en-gb/media/our-response-to-covid-19/","https://www.gsk.com/speakup","https://glaxosmithkline.co.jp/legal/inquire3_1.html?about=donation&ref=GSKCorporate","https://medical.gsk.com/ja-jp/","https://www.egpa.jp/","https://www.gsk.com/en-gb/responsibility/esg-resources/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/immunologyrespiratory/","https://www.gsk.com/media/10013/q1-2023-results-announcement.pdf","https://viivhealthcare.com/ja-jp/","https://www.gsk.com/media/10423/q2-2023-results-announcement.pdf","https://glaxosmithkline.co.jp/corp/compliance/view/index2021.html","https://www.zensoku.jp/","https://lin.ee/674pSLG","https://www.gsk.com/en-gb/media/press-releases/gsk-and-viiv-healthcare-to-present-scientific-advancements-at-idweek-2023/","https://www.gsk-savethechildren.com/","https://rsvirus.jp/","https://www.gsk.com/media/10667/q3-2023_31-october_final.pdf","https://zensoku.jp/","https://youtu.be/DzEwmhXsaRE","https://www.gsk.com/media/10928/fy-2023-results-announcement.pdf","https://www.gsk.com/media/9281/position-on-working-with-third-parties-2023.pdf","https://with-sle.jp/","https://www.gsk.com/en-gb/media/press-releases/dreamm-7-phase-iii-trial-shows-pfs-improvement-and-strong-os-trend-for-blenrep-combo-versus-soc-combo-in-multiple-myeloma/","https://www.gsk.com/en-gb/investors/quarterly-results/","https://www.gsk.com/media/11099/q1-2024-results-announcement.pdf","https://www.gsk.com/en-gb/media/press-releases/positive-ruby-phase-iii-data-show-potential-for-jemperli-dostarlimab-combinations-in-more-patients-with-primary-advanced-or-recurrent-endometrial-cancer/","https://www.gsk.com/en-gb/media/press-releases/blenrep-combination-reduced-the-risk-of-disease-progression/","https://www.gsk.com/media/11412/q2-2024-results-announcement.pdf","https://glaxosmithkline.co.jp/corp/compliance/view/index2022.html","https://youtu.be/qNK8ftLE8F8","https://youtu.be/_DJW9Rg5o-M","https://www.gsk.com/en-gb/contact-us/","https://www.gsk.com/en-gb/media/press-releases/gsk-receives-us-fda-fast-track-designation-for-bepirovirsen-in-chronic-hepatitis-b/","https://www.gsk.com/en-gb/responsibility/environment/climate/","https://www.gsk.com/en-gb/responsibility/global-health-and-health-security/global-health/","https://www.gsk.com/en-gb/responsibility/global-health-and-health-security/health-security/","https://www.gsk.com/en-gb/responsibility/environment/","https://www.gsk.com/en-gb/responsibility/","https://www.gsk.com/media/11646/q3-2024-results-announcement.pdf","https://www.gsk.com/en-gb/investors/financial-reports/annual-report-2023/","https://www.gsk.com/media/11009/esg-performance-report-2023.pdf","https://www.gsk.com/media/10999/environmental-data-2023.pdf","https://www.gsk.com/media/11010/pathway-to-a-net-zero-impact-on-climate.pdf","https://www.gsk.com/media/10534/nature-report-september-2023.pdf","https://www.gsk.com/media/11014/basis-of-reporting-environmental-data-2023.pdf","https://www.gsk.com/en-gb/behind-the-science-magazine/health-equity-gap-medicine-vaccine-access/","https://www.gsk.com/en-gb/innovation/trials/diversity-in-clinical-trials/","https://www.gsk.com/en-gb/responsibility/charitable-investments/","https://www.gsk.com/media/10994/uk-gender-pay-gap-report-2023.pdf","https://www.gsk.com/media/10995/uk-ethnicity-pay-gap-report-2023.pdf","https://www.gsk.com/en-gb/media/press-releases/blenrep-belantamab-mafodotin-in-combination-receives-breakthrough-therapy-designation-in-china-for-treatment-of-relapsedrefractory-multiple-myeloma/","https://www.gsk.com/en-gb/media/press-releases/us-fda-advisory-committee-votes-in-support-of-trials-designed-to-evaluate-jemperli-dostarlimab-gxly-as-a-potential-treatment-for-dmmrmsi-h-locally-advanced-rectal-cancer/","https://www.gsk.com/en-gb/media/press-releases/gsk-receives-us-fda-breakthrough-therapy-designation/","https://www.gsk.com/en-gb/media/press-releases/gsk-enters-exclusive-license-agreement-with-hansoh-for-hs-20093/","https://www.gsk.com/media/11776/fy-2024-results-announcement.pdf","https://www.gsk.com/en-gb/media/press-releases/depemokimab-delivers-clinically-meaningful-and-statistically-significant-improvements-for-patients-with-chronic-rhinosinusitis-with-nasal-polyps-crswnp/","https://www.gsk.com/en-gb/investors/","https://kotsuzui-senisho.jp/","https://www.gsk.com/en-gb/innovation/our-leading-scientists/","https://glaxosmithkline.co.jp/legal/inquire3_1.html?about=sideeffect&ref=GSKpro","https://www.gsk.com/en-gb/media/press-releases/blenrep-combinations-accepted-for-review-by-the-us-fda-for-the-treatment-of-relapsedrefractory-multiple-myeloma/","https://www.gsk.com/en-gb/media/press-releases/blenrep-belantamab-mafodotin-combinations-in-multiple-myeloma-application-accepted-for-review-by-the-european-medicines-agency/","https://www.gsk.com/en-gb/media/press-releases/blenrep-belantamab-mafodotin-combinations-in-relapsedrefractory-multiple-myeloma-accepted-for-regulatory-review-in-japan/","https://www.gsk.com/en-gb/media/press-releases/blenrep-belantamab-mafodotin-combination-accepted-for-priority-review-in-china-in-relapsedrefractory-multiple-myeloma/","https://www.gsk.com/media/11776/fy-2024-results-announcement.pdf","https://www.gsk.com/media/11962/q1-2025-results-announcement.pdf","https://www.gskgrants.com/","https://taijouhoushin-yobou.jp/info-search.html","https://youtu.be/-1PHXPEH298","https://www.gsk.com/en-gb/investors/financial-reports/annual-report-2024/","https://www.gsk.com/en-gb/responsibility/responsibility-reports/","https://www.gsk.com/media/11849/environmental-data-2024.pdf","https://www.instagram.com/gsk_japan/","https://supplier.gsk.com/","https://tahatsusei-kotsuzuishu.jp/"]},"settings":{"optionalStylesheetLink":"/media/qm1p21vs/optional_style_u13_jp.css","themeColorHexCode":null,"headerLogoLightTheme":null,"headerLogoDarkTheme":null,"footerLogo":{"src":"https://jp.gsk.com/media/3rjfqjwb/gsk-logo.png?width=104&format=webp&quality=100&v=1dc0141fa7adc10","alt":"GSK Logo","darkModeSrc":"https://jp.gsk.com/media/3rjfqjwb/gsk-logo.png?width=104&format=webp&quality=90&v=1dc0141fa7adc10"},"scripts":[{"pageLocation":"Top","text":" \n"}],"globalWebsiteLink":{"text":"Global","href":"https://www.gsk.com","target":"_blank","openInNewWindowText":"新しいウィンドウで開く"},"googleMapsApiKey":"AIzaSyA2QMg4Ww6djPKb7b9BraQn4kgJmDaLblg","textToSpeechApiKey":"","bingVerificationCode":"","googleAnalytics":"","siteTitle":" | GSK グラクソ･スミスクライン"},"pageSettings":{"disableBackToTopButton":false,"backToTopButtonText":"トップへ戻る","robotsNoFollow":false,"robotsNoIndex":false,"canonicalUrl":"https://jp.gsk.com/ja-jp/careers/"},"tealiumSettings":{"enabled":false,"data":""},"entryPopup":null,"protectedPage":false,"schema":null,"modules":[{"type":"hero-banner","items":[{"label":"採用情報","heroTextStyle":"big","title":"病に先手を打つ、私たち一人ひとりの想いです","subText":"GSKで働く私たちには、病気に先手を打ちたいという、それぞれの想いがあります。最先端の科学とテクノロジー、そして才能ある人々が力を合わせることで、今後10年の間に25億人の健康に良い影響を与えることを目指しています。ぜひ一緒にこの旅路を歩みませんか？","showPinch":false,"image":{"src":"/media/0hebnqyu/_s3a0516.jpg?rxy=0.39689578713968959,0.56810631229235875&width=890&height=712&format=webp&quality=100&v=1dc0141e30db2a0","alt":"採用情報","darkModeSrc":"/media/0hebnqyu/_s3a0516.jpg?rxy=0.39689578713968959,0.56810631229235875&width=890&height=712&format=webp&quality=90&v=1dc0141e30db2a0"},"previewVideo":null,"fullVideo":null,"videoDuration":"","caption":"","subtitles":null,"orangeLink":null,"underlineLink":null,"ariaHidden":false,"orangeLinkAriaLabel":""}],"animationSwitchWhite":false},{"type":"icims-search-box","title":"","localeCode":"ja-jp","formAction":"https://jobs.gsk.com/ja-jp/jobs","keywordsPlaceholder":"職種を入力してください","locationPlaceholder":"ロケーションを入力してください","searchButtonText":"求人を検索する"},{"type":"spacer","label":""},{"type":"cards","header":"GSKで働くということ","subtext":"","cards":[{"type":"flip-card","heading":"価値ある変化を起こす","text":"イノベーション、大きな影響力、そして世界をつなぐパートナーシップによって、数十億人の命や生活に良い影響を与える特別な機会になります。
","image":{"src":"/media/dtdlrnjb/make-a-difference-with-us.jpg?width=420&height=336&format=webp&quality=100&v=1dc7489009c7f30","alt":"価値ある変化を起こす","darkModeSrc":"/media/dtdlrnjb/make-a-difference-with-us.jpg?width=420&height=336&format=webp&quality=90&v=1dc7489009c7f30"},"ariaHidden":false},{"type":"flip-card","heading":"共にベストを尽くす","text":"病気に先手を打つためには、社員一人ひとりが成長し続けることが必要です。GSKはスキルアップとネットワーク構築を支援し、最高の成果を出せる環境を提供しています。
","image":{"src":"/media/2w2lkdio/do-your-best-with-us.webp?width=420&height=336&format=webp&quality=100&v=1dc748900b6e500","alt":"共にベストを尽くす","darkModeSrc":"/media/2w2lkdio/do-your-best-with-us.webp?width=420&height=336&format=webp&quality=90&v=1dc748900b6e500"},"ariaHidden":false},{"type":"flip-card","heading":"自分らしく働く","text":"GSKは誰もが受け入れられ、支え合う文化を築いています。大切なものを犠牲にすることなく、仕事での目標に向かって進むことができます。
","image":{"src":"/media/xxsd1bz4/be-yourself.jpg?width=420&height=336&format=webp&quality=100&v=1dc748900befb50","alt":"自分らしく働く","darkModeSrc":"/media/xxsd1bz4/be-yourself.jpg?width=420&height=336&format=webp&quality=90&v=1dc748900befb50"},"ariaHidden":false}],"link":null,"ariaLabelPreviousSlide":"Previous slide","ariaLabelNextSlide":"Next slide"},{"type":"spacer","label":""},{"type":"rich-text","text":"私たちは優れた人財を結集し、患者さんのために高い志を持って行動し、世界中の何百万もの人々の健康に長く続く変化をもたらそうとしています。
\n今ほどワクワクする時はありません。人々の健康にとって新しい時代が始まり、私たちの取り組みはこれまでになく重要になっています。医療が直面する大きな課題に共に取り組み、病気に先手を打っていきましょう。
\n","useGreyBackground":false,"fullWidth":false},{"type":"spacer","label":""},{"type":"varied-signpost-grid","title":"こちらもご覧ください","layoutPattern":4,"pages":[{"title":"社員の声","content":"グラクソ・スミスクライン株式会社で働く社員の一部をご紹介します。","image":{"src":"/media/jt0ntghi/oncology_r_01.jpg?width=427&height=533&format=webp&quality=100&v=1dc0141e4173360","alt":"Oncology Medical Project Manager","darkModeSrc":"/media/jt0ntghi/oncology_r_01.jpg?width=427&height=533&format=webp&quality=90&v=1dc0141e4173360"},"link":{"text":"Our people Interview","href":"/ja-jp/careers/our-people-interview/","openInNewWindowText":null}},{"title":"企業責任","content":"GSKでは、サイエンス、テクノロジー、人財を結集し、力を合わせて病に先手を打つ、という存在意義を事業の指針として掲げています。","image":{"src":"/media/242kdja3/_s3a1171.jpg?width=427&height=533&format=webp&quality=100&v=1dc01419272c790","alt":"企業責任","darkModeSrc":"/media/242kdja3/_s3a1171.jpg?width=427&height=533&format=webp&quality=90&v=1dc01419272c790"},"link":{"text":"Responsibility","href":"/ja-jp/responsibility/","openInNewWindowText":null}},{"title":"存在意義・戦略・カルチャー","content":"GSKは、サイエンス、テクノロジー、人財を結集し、力を合わせて病に先手を打つ、という存在意義を持った、グローバルなバイオ医薬品企業です。私たちは、今後10年間で25億の人々の健康に貢献し、社員が生き生きと活躍しながら成長できる企業として成功することを目指しています。","image":{"src":"/media/psrlzurd/gsk_tech_human_image_6k_30056.png?width=427&height=533&format=webp&quality=100&v=1dc0141891810b0","alt":"存在意義・戦略・カルチャー","darkModeSrc":"/media/psrlzurd/gsk_tech_human_image_6k_30056.png?width=427&height=533&format=webp&quality=90&v=1dc0141891810b0"},"link":{"text":"Purpose strategy and culture","href":"/ja-jp/company/purpose-strategy-and-culture/","openInNewWindowText":null}}],"hidePageDescription":false,"useGreyBackground":false}]}